Should You Add CNS Pharmaceuticals Inc (CNSP) Stock to Your Portfolio Monday?

A rating of 14 puts CNS Pharmaceuticals Inc (CNSP) near the top of the Healthcare sector according to InvestorsObserver. CNS Pharmaceuticals Inc's score of 14 means that it ranks higher than 14% of stocks in the sector. In addition, its overall score of 18 ranks it higher than 18% of all stocks.

CNSP has an Overall Score of 18. Find out what this means to you and get the rest of the rankings on CNSP!

See Full CNSP Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With CNS Pharmaceuticals Inc Stock Today?

CNS Pharmaceuticals Inc (CNSP) stock has gained 0.48% while the S&P 500 is lower by -0.02% as of 10:00 AM on Monday, Oct 23. CNSP has risen $0.01 from the previous closing price of $2.08 on volume of 8,973 shares. Over the past year the S&P 500 has gained 11.22% while CNSP is lower by -59.96%. CNSP lost -$9.90 per share the over the last 12 months. Click Here to get the full Stock Report for CNS Pharmaceuticals Inc stock.